BioSpace News Archive

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the appointment of Judy Caron , Ph.D., as Vice President of Drug Development. Dr. Caron has 30 years of experience in biopharmaceutical development.

Kindred Biosciences, Inc. announced positive results from its pilot field efficacy study of KIND-025, a canine fusion protein targeting interleukin-4 and interleukin-13, for the treatment of atopic dermatitis in dogs.

Improved Navigation and Functionality Supports Increased Virtual Connectivity with Customers, Collaborators and Growers

Shareholder proxy vote achieves quorum with 99% support for the transaction Final step in OpGen / Curetis business combination achieved pending results of Special Meeting GAITHERSBURG, Md., March 24, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today an update on shareholder proxy voting in relation to the business combination with Curetis.

AXIM ® Biotechnologies, Inc . announced today that its subsidiary Sapphire Biotech, Inc. (“Sapphire”) has completed pre-clinical drug studies on a new compound, SPX-1009, demonstrating 10 times greater potency than its parent compound, SBI-183, in inhibiting metastasis. “Cancer

The map identifies populations likely to experience severe outcomes once infected and the socioeconomic drivers for that risk, helping community leaders and healthcare providers deploy interventions and allocate resources

New Indication for Epic Hygiene Laser Provides Highly Effective, Noninvasive Reduction of Bacterial Level and Inflammation

Hoth Therapeutics, Inc. today announced the pricing of its previously announced “best efforts” underwritten public offering of 1,449,275 shares of its common stock at a price to the public of $3.45 per share. Hoth expects to receive aggregate gross proceeds of approxi

Grant of $1 million used to finalize development and deployment of existing assay to triage coronavirus patients

Premier Medical Laboratory Services (PMLS), an industry leading diagnostic laboratory, headquartered in Greenville, South Carolina, is announcing today they are now validated for COVID-19 testing.